Nearmap Ltd buy krebskrebs
Start price
22.02.21
/
50%
€1.69
Target price
22.02.22
€2.50
Performance (%)
-54.14%
End price
23.02.22
€0.78
Summary
This prediction ended on 23.02.22 with a price of €0.78. The BUY prediction by krebskrebs for Nearmap Ltd performed very badly with a performance of -54.14%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Nearmap Ltd | - | - | - | - |
| iShares Core DAX® | 1.301% | -1.386% | 12.259% | 59.752% |
| iShares Nasdaq 100 | 0.612% | -4.172% | 1.687% | 86.147% |
| iShares Nikkei 225® | 8.772% | 9.777% | 30.041% | 63.047% |
| iShares S&P 500 | 0.254% | -2.301% | 0.794% | 57.981% |
Comments by krebskrebs for this prediction
In the thread Nearmap Ltd diskutieren
Buy mit Kursziel 2,5
In the thread Trading Nearmap Ltd
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

